Abstract
The bulgecins are iminosaccharide secondary metabolites of the Gram-negative bacterium Paraburkholderia acidophila and inhibitors of lytic transglycosylases of bacterial cell-wall biosynthesis and remodeling. The activities of the bulgecins are intimately intertwined with the mechanism of a co-biosynthesized β-lactam antibiotic. β-Lactams inhibit the penicillin-binding proteins, enzymes also critical to cell-wall biosynthesis. The simultaneous loss of the lytic transglycosylase (by bulgecin) and penicillin-binding protein (by β-lactams) activities results in deformation of the septal cell wall, observed microscopically as a bulge preceding bacterial cell lysis. We describe a practical synthesis of the three naturally occurring bulgecin iminosaccharides and their mechanistic evaluation in a series of microbiological studies. These studies identify potentiation by the bulgecin at sub-minimum inhibitory concentrations of the β-lactam against three pathogenic Gram-negative bacteria, and establish for the first time that this potentiation results in a significant increase in the bactericidal efficacy of a clinical β- lactam.
Funding Information
  • Uehara Memorial Foundation (Postdoctoral Fellowship)
  • NIH (T32GM075762, AI113219, GM61629)

This publication has 54 references indexed in Scilit: